UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Commonwealth Financial Services LLC

Commonwealth Financial Services LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.0% during the second quarter, HoldingsChannel reports. The fund owned 726 shares of the healthcare conglomerate’s stock after acquiring an additional 60 shares during the quarter. Commonwealth Financial Services LLC’s holdings in UnitedHealth Group were worth $355,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Macroview Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group during the second quarter worth about $31,000. Finally, Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Robert W. Baird boosted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Monday, September 16th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. TD Cowen lifted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $614.17.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $575.00 on Monday. The company has a market cap of $529.22 billion, a P/E ratio of 35.15, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The business’s 50-day simple moving average is $577.10 and its 200 day simple moving average is $521.14. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the business earned $6.14 EPS. The business’s revenue was up 6.4% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.